If you liked this article you might like

Week Ahead: Earnings Come in Thick and Fast in a Middling First-Quarter Reporting Season
Top 7 Financial Stocks to Own for 2017
Baker's Dozen Plus One Make Up My New Buyback/Dividend Growth Portfolio
Bristol-Myers Squibb, Merck, Synergy Pharmaceuticals: Doug Kass' Views